Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKTS compared with CGON: revenue, margins and what each company keeps, and the suppliers and customers both name
AKTS
Aktis Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
CGON
CG Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKTS
Aktis Oncology, Inc.
vs
CGON
CG Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
AKTS: latest quarter is a loss; flow not drawable. CGON: latest quarter is a loss; flow not drawable.
Method
›
AKTS
Aktis Oncology, Inc.
Change
14.63
· pre 14.04
· delayed
Mkt cap
$826.2M
Revenue
$3M
Q2 FY26
CGON
CG Oncology, Inc.
Change
64.15
· pre 64.16
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$5.7B
Revenue
$1M
Q2 FY26
vs
Compare
Pre-market
Nov 4 '26
delayed
AKTS
Aktis Oncology, Inc.
vs
CGON
CG Oncology, Inc.
14.63
pre 14.04
delayed
Price
64.15
pre 64.16
delayed
$826.2M
Mkt cap
$5.7B
Q2 FY26
$3M
Revenue
$1M
Q2 FY26
Change
Change
AKTS
14.63
vs
CGON
64.15
Pre-market
Nov 4 '26
delayed
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AKTS, solid
CGON, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: AKTS, CGON.
Role chip = supplier or customer
Source: SEC EDGAR